Find information on thousands of medical conditions and prescription drugs.

Alport syndrome

Alport syndrome is a genetic condition characterized by the progressive loss of kidney function and hearing. Alport syndrome can also affect the eyes. The presence of blood in the urine (hematuria) is almost always found in this condition. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current
From Biophysical Journal, 10/1/02 by Angelo, Kamilla

ABSTRACT The function of the KCNE5 (KCNE1-like) protein has not previously been described. Here we show that KCNE5 induces both a time- and voltage-dependent modulation of the KCNQ1 current. Interaction of the KCNQ1 channel with KCNE5 shifted the voltage activation curve of KCNQ1 by more than 140 mV in the positive direction. The activation threshold of the KCNQ1 +KCNE5 complex was +40 mV and the midpoint of activation was +116 mV. The KCNQ1+KCNE5 current activated slowly and deactivated rapidly as compared to the KCNQ1+KCNE1 at 22 degC; however, at physiological temperature, the activation time constant of the KCNQ1 +KCNE5 current decreased fivefold, thus exceeding the activation rate of the KCNQ1+KCNE1 current. The KCNE5 subunit is specific for the KCNQ1 channel, as none of other members of the KCNQ-family or the human ether a-go-go related channel (hERG1) was affected by KCNE5. Four residues in the transmembrane domain of the KCNE5 protein were found to be important for the control of the voltage-dependent activation of the KCNQ1 current. We speculate that since KCNE5 is expressed in cardiac tissue it may here along with the KCNE1 beta-subunit regulate KCNQ1 channels. It is possible that KCNE5 shapes the /^sub Ks^ current in certain parts of the mammalian heart.

INTRODUCTION

It has become clear that channels are composed of numerous units, which engage into larger complexes. Often the pore-forming alpha-subunits interact with other membrane proteins and/or couple to cytosolic components that contribute to the features of the channel. Some accessory proteins change the sensitivity of the alpha-subunit to e.g., Ca^sup 2+^, pH, temperature, cell volume changes, or second messengers. They may direct the membrane localization of channels, couple channels to the cytoskeleton, or regulate the expression level of channels. Basic channel properties such as selectivity, conductance, voltage-dependency and pharmacological profile can be changed by these subunit-interactions to an extent where the biophysical characteristics of the alpha-subunit become difficult to recognize. Several important native currents have been proven to be composed of such subunits interacting in a non-trivial fashion (Seino, 1999; Peleg et al., 2002).

The KCNE-family is a group of small proteins, which interact with voltage-gated potassium channels. The length of the KCNE proteins is between 130 and 167 amino acids and they contain one transmembrane domain flanked by an extracellular N-terminal and a cytosolic C-terminal. The first member of the family, KCNE1 (minK), was cloned in 1988 (Takumi et al., 1988) and in 1999, Abbott et al. isolated KCNE2, 3 and 4 (MiRP1-3) (Abbott et al., 1999). The functional effect of KCNE on the KCNQ1 channel is that the current activates and deactivates slower than when the KCNQI alpha-subunit is alone. The voltage sensitivity of the KCNQ1+KCNE1 current is shifted toward positive potentials and the whole-cell current density is increased. Furthermore, assembly of KCNQI with the KCNE1 subunit increases the unitary conductance by fourfold (Sesti and Goldstein, 1998). The current formed by the KCNQ1 +KCNE1 complex corresponds to the slow delayed rectifier current, I^sub Ks^, in cardiac myocytes (Sanguinetti et al., 1996; Barhanin et al., 1996). An interaction between KCNE3 and KCNQI gives rise to a constitutively open potassium channel that plays a role in cyclic AMP-stimulated C1^sup -^ secretion (Schroeder et al., 2000; Grahammer et al., 2001). Expression of KCNQ1 together with KCNE2 in COS cells results in an effect similar to that of the KCNE3; the KCNQ1 channel transforms into a voltage-- independent channel (Tinel et al., 2000a).

In 1999 Piccini et al. isolated a gene, which they refer to as the KCNE1-like gene. The KCNE1-like gene is one of the four genes that are deleted in the AMME contiguous gene syndrome (Jonsson et al., 1998). The human KCNE1-like protein shows 56% homology with KCNE1. It is composed of 142 amino acids and like the other members of the KCNE-family it has a single putative transmembrane domain. The KCNE1-like gene has lately been suggested to be the fifth member of the KCNE family and is now referred to as KCNE5 (Abbott et al., 2001). To date the function of the KCNE5 protein has not been established. Here we demonstrate that the KCNQI current is markedly influenced by the presence of KCNE5. We show that the KCNE5 beta-subunit affects the activation kinetics of the KCNQ1 current in the same direction as observed for the KCNE1+KCNQI complex; however, to a much greater extend. The voltage-activation curve of the KCNQ I current is shifted in the positive direction toward an activation threshold of +40 mV. Thus, the KCNQ1 +KCNE5 complex only conducts current upon strong and continued depolarization. The effect of KCNE5 was specific for KCNQ1 channels; the other KCNQ channels or the human ether a-go-go related channel (hERG1) was not affected by coexpressed KCNE5. Mutagenesis experiments showed that four specific amino acids in the transmembrane domain of KCNE5 are responsible for the regulatory effect.

We thank Inge Kjeldsen and Pia Hageman for technical assistance. This study was supported by the Danish Heart Association.

REFERENCES

Abbott, G. W., M. H. Butler, S. Bendahhou, M. C. Dalakas, L. J. Ptacek, and S. A. Goldstein. 2001. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell. 104:217-231.

Abbott, G. W., F. Sesti, I. Splawski, M. E. Buck, M. H. Lehmann, K. W. Timothy, M. T. Keating, and S. A. Goldstein. 1999. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 97:175-187.

Barhanin, J., F. Lesage, E. Guillemare, M. Fink, M. Lazdunski, and G. Romey. 1996. K(V)LQT1 and IsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 384:78-80.

Baud, C., R. T. Kado, and K. Marcher. 1982. Sodium channels induced by depolarization of the Xenopus laevis oocyte. Proc. Natl. Acad. Sci. U.S.A. 79:3188-3192.

Franco, D., S. Demolombe, S. Kupershmidt, R. Dumaine, J. N. Dominguez, D. Roden, C. Antzelevitch, D. Escande, and A. F. Moorman. 2001. Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. Cardiovasc. Res. 52:65-75.

Grahammer, F., R. Warth, J. Barhanin, M. Bleich, and M. J. Hug. 2001. The small conductance K+ channel, KCNQ1: expression, function, and subunit composition in marine trachea. J. Biol. Chem. 276: 42268-42275.

Grunnet, M., B. S. Jensen, S. P. Olesen, and D. A. Klaerke. 2001. Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch. 441:544-550.

Jespersen, T., M. Grunnet, K. Angelo, D. Klaerke, and S. Olesen. 2002. Dual-function vector for protein expression in both mammalian cells and Xenopus laevis Oocytes. Biotechniques. 32:536-540.

Jonsson, J. J., A. Renieri, P. G. Gallagher, C. E. Kashtan, E. M. Cherniske, M. Bruttini, M. Piccini, F. Vitelli, A. Ballabio, and B. R. Pober. 1998. Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome? J. Med. Genet. 35:273-278.

Kharkovets, T., J. P. Hardelin, S. Safieddine, M. Schweizer, A. El Amraoui, C. Petit, and T. J. Jentsch. 2000. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc. Natl. Acad. Sci. U.S.A. 97: 4333-4338.

McDonald, T. V., Z. Yu, Z. Ming, E. Palma, M. B. Meyers, K. W. Wang, S. A. Goldstein, and G. I. Fishman. 1997. A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature. 388:289-292.

Melman, Y. F., A. Domenech, L. S. de la, and T. V. McDonald. 2001. Structural determinants of KvLQTI control by the KCNE family of proteins. J. Biol. Chem. 276:6439-6444.

Nerbonne, J. M. 2000. Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J. Physiol. 525 Pt 2:285-298.

Peleg, S., D. Varon, T. Ivanina, C. W. Dessauer, and N. Dascal. 2002. Ga(i) controls the gating of the G protein-activated K(+) channel, GIRK. Neuron. 33:87-99.

Piccini, M., F. Vitelli, M. Seri, L. J. Galietta, 0. Moran, A. Bulfone, S. Banfi, B. Pober, and A. Renieri. 1999. KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs. Genomics. 60:251-257.

Robbins, J. 2001. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. PharmacoL Ther. 90:1-19.

Rosati, B., Z. Pan, S. Lypen, H. S. Wang, I. Cohen, J. E. Dixon, and D. McKinnon. 2001. Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J. Physiol. 533:119-125.

Sanguinetti, M. C. 1999. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann. N. Y. Acad. Sci. 868: 406-413.

Sanguinetti, M. C., M. E. Curran, A. Zou, J. Shen, P. S. Spector, D. L. Atkinson, and M. T. Keating. 1996. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 384:80-83.

Schroeder, B. C., S. Waldegger, S. Fehr, M. Bleich, R. Warth, R. Greger, and T. J. Jentsch. 2000. A constitutively open potassium channel formed by KCNQI and KCNE3. Nature. 403:196-199.

Seino, S. 1999. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Annu. Rev. Physiol. 61: 337-362.

Sesti, F. and S. A. Goldstein. 1998. Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. J. Gen. Physiol. 112:651-663.

Sigworth, F. J., H. Affolter, and E. Neher. 1995. Design of the EPC-9, a computer-controlled patch-clamp amplifier. 2. Software. J. Neurosci. Methods. 56:203-215.

Strobaek, D., T. D. Jorgensen, P. Christophersen, P. K. Ahring, and S. P. Olesen. 2000. Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells. Br. J. PharmacoL 129:991-999.

Takumi, T., H. Ohkubo, and S. Nakanishi. 1988. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 242:1042-1045.

Tinel, N., S. Diochot, A Borsotto, M. Lazdunski, and J. Barhanin. 2000a. KCNE2 confers background current characteristics to the cardiac KCNQI potassium channel. EMBO J. 19:6326-6330.

Tinel, N., S. Diochot, I. Lauritzen, J. Barhanin, M. Lazdunski, and M. Borsotto. 2000b. M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit. FEBS Lett. 480:137-141.

Yu, H., J. Wu, I. Potapova, R. T. Wymore, B. Holmes, J. Zuckerman, Z. Pan, H. Wang, W. Shi, R. B. Robinson, M. R. El Maghrabi, W. Benjamin, J. Dixon, D. McKinnon, I. S. Cohen, and R. Wymore. 2001. MinK-related peptide 1: A beta subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ. Res. 88:E84-E87.

Zhang, M., M. Jiang, and G. N. Tseng. 2001. minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel? Circ. Res. 88:1012-1019.

Kamilla Angelo, Thomas Jespersen, Morten Grunnet, Morten Schak Nielsen, Dan A. Klaerke, and Soren-Peter Olesen

Department of Medical Physiology, University of Copenhagen, The Panum Institute, Copenhagen, Denmark

Submitted March 12, 2002, and accepted for publication May 30, 2002.

Address reprint requests to Kamilla Angelo, Dept. of Medical Physiology, University of Copenhagen, The Panum Inst, Blegdamsvej 3, Copenhagen 2200 N, Denmark. Tel.: 45 35327445; Fax: 45 35327555; E-mail: angelo@mfi.ku.dk.

Copyright Biophysical Society Oct 2002
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Alport syndrome
Home Contact Resources Exchange Links ebay